Literature DB >> 15456904

Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line.

Adam J Carpenter1, Andrew C G Porter.   

Abstract

DNA Topoisomerase IIalpha (topoIIalpha) is a DNA decatenating enzyme, abundant constituent of mammalian mitotic chromosomes, and target of numerous antitumor drugs, but its exact role in chromosome structure and dynamics is unclear. In a powerful new approach to this important problem, with significant advantages over the use of topoII inhibitors or RNA interference, we have generated and characterized a human cell line (HTETOP) in which >99.5% topoIIalpha expression can be silenced in all cells by the addition of tetracycline. TopoIIalpha-depleted HTETOP cells enter mitosis and undergo chromosome condensation, albeit with delayed kinetics, but normal anaphases and cytokineses are completely prevented, and all cells die, some becoming polyploid in the process. Cells can be rescued by expression of topoIIalpha fused to green fluorescent protein (GFP), even when certain phosphorylation sites have been mutated, but not when the catalytic residue Y805 is mutated. Thus, in addition to validating GFP-tagged topoIIalpha as an indicator for endogenous topoIIalpha dynamics, our analyses provide new evidence that topoIIalpha plays a largely redundant role in chromosome condensation, but an essential catalytic role in chromosome segregation that cannot be complemented by topoIIbeta and does not require phosphorylation at serine residues 1106, 1247, 1354, or 1393.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456904      PMCID: PMC532048          DOI: 10.1091/mbc.e04-08-0732

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  64 in total

1.  Decreased topoisomerase IIalpha expression confers increased resistance to ICRF-193 as well as VP-16 in mouse embryonic stem cells.

Authors:  M Kobayashi; N Adachi; Y Aratani; A Kikuchi; H Koyama
Journal:  Cancer Lett       Date:  2001-05-10       Impact factor: 8.679

2.  Mapping of a human centromere onto the DNA by topoisomerase II cleavage.

Authors:  G Floridia; A Zatterale; O Zuffardi; C Tyler-Smith
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

Review 3.  Shaping the metaphase chromosome: coordination of cohesion and condensation.

Authors:  A Losada; T Hirano
Journal:  Bioessays       Date:  2001-10       Impact factor: 4.345

Review 4.  Chromosome cohesion, condensation, and separation.

Authors:  T Hirano
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

5.  Premitotic chromosome individualization in mammalian cells depends on topoisomerase II activity.

Authors:  J F Giménez-Abián; D J Clarke; J Devlin; M I Giménez-Abián; C De la Torre; R T Johnson; A M Mullinger; C S Downes
Journal:  Chromosoma       Date:  2000-07       Impact factor: 4.316

6.  Chromosome assembly in vitro: topoisomerase II is required for condensation.

Authors:  Y Adachi; M Luke; U K Laemmli
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

7.  The human decatenation checkpoint.

Authors:  P B Deming; C A Cistulli; H Zhao; P R Graves; H Piwnica-Worms; R S Paules; C S Downes; W K Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

8.  Live fluorescence imaging reveals early recruitment of emerin, LBR, RanBP2, and Nup153 to reforming functional nuclear envelopes.

Authors:  T Haraguchi; T Koujin; T Hayakawa; T Kaneda; C Tsutsumi; N Imamoto; C Akazawa; J Sukegawa; Y Yoneda; Y Hiraoka
Journal:  J Cell Sci       Date:  2000-03       Impact factor: 5.285

9.  Active, but not inactive, human centromeres display topoisomerase II activity in vivo.

Authors:  Claus L Andersen; Annelise Wandall; Eigil Kjeldsen; Christian Mielke; Jørn Koch
Journal:  Chromosome Res       Date:  2002       Impact factor: 4.620

10.  Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds.

Authors:  B van Hille; X Clerc; A M Creighton; B T Hill
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

View more
  71 in total

1.  Effects of conditional depletion of topoisomerase II on cell cycle progression in mammalian cells.

Authors:  Ruth E Gonzalez; Chang-Uk Lim; Kelly Cole; Christine Hanko Bianchini; Gary P Schools; Brian E Davis; Ikuo Wada; Igor B Roninson; Eugenia V Broude
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

2.  Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II.

Authors:  Chung-Pei Lee; Jen-Yang Chen; Jiin-Tarng Wang; Keiji Kimura; Ai Takemoto; Chih-Chung Lu; Mei-Ru Chen
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

3.  Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads.

Authors:  Jennifer M Spence; Hui Hui Phua; Walter Mills; Adam J Carpenter; Andrew C G Porter; Christine J Farr
Journal:  J Cell Sci       Date:  2007-10-23       Impact factor: 5.285

Review 4.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

5.  Old drug, new target: ellipticines selectively inhibit RNA polymerase I transcription.

Authors:  William J Andrews; Tatiana Panova; Christophe Normand; Olivier Gadal; Irina G Tikhonova; Konstantin I Panov
Journal:  J Biol Chem       Date:  2013-01-04       Impact factor: 5.157

Review 6.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

7.  Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.

Authors:  Yang Wang; Robert J Coffey; Neil Osheroff; Kristi L Neufeld
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  Mitotic chromosomes are constrained by topoisomerase II-sensitive DNA entanglements.

Authors:  Ryo Kawamura; Lisa H Pope; Morten O Christensen; Mingxuan Sun; Ksenia Terekhova; Fritz Boege; Christian Mielke; Anni H Andersen; John F Marko
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

9.  Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.

Authors:  J J Bower; G F Karaca; Y Zhou; D A Simpson; M Cordeiro-Stone; W K Kaufmann
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

Review 10.  Topoisomerase II: a fitted mechanism for the chromatin landscape.

Authors:  Joaquim Roca
Journal:  Nucleic Acids Res       Date:  2008-12-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.